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E-mail address: hiroshi.takaku@it-chiba.ac.jp (H. TDouble-stranded RNAs suppress the expression of homologous genes through an evolutionarily con-
served process called RNA interference (RNAi) or post-transcriptional gene silencing. A bidentate
nuclease called Dicer has been implicated as the protein responsible for the production of short
interfering RNAs (siRNAs). In our experiments, Rex overexpression reduced the efﬁciency of short
hairpin RNA (shRNA)-mediated RNAi. The interaction of Dicer with Rex inhibited the conversion
of shRNA to siRNA. These results suggest that the interaction of Dicer with HTLV-I Rex inhibits Dicer
activity and thereby reduces the efﬁciency of the conversion of shRNA to siRNA.
Structured summary:
MINT-7996954: Rex (uniprotkb:P0C205) physically interacts (MI:0915) with Dicer (uniprotkb:Q9UPY3) by
pull down (MI:0096)
MINT-7996926: Rex (uniprotkb:P0C205) and Dicer (uniprotkb:Q9UPY3) colocalize (MI:0403) by ﬂuores-
cence microscopy (MI:0416)
MINT-7996905: Dicer (uniprotkb:Q9UPY3) physically interacts (MI:0915) with Rex (uniprotkb:P0C205) by
anti bait coimmunoprecipitation (MI:0006)
MINT-7996852, MINT-7996870, MINT-7996886, MINT-7996830: Rex (uniprotkb:P0C205) physically inter-
acts (MI:0915) with Dicer (uniprotkb:Q9UPY3) by anti tag coimmunoprecipitation (MI:0007)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction proteins that are known to directly interact with Dicer in mammalsRNA interference (RNAi)-mediated reactions have recently
emerged as important pathways that regulate eukaryotic gene
expression at various levels [1–3]. The speciﬁcity of these pro-
cesses depends on 20- to 25-nucleotide (nt) small interfering RNAs
(siRNAs) that act as guides that recognize target nucleic acid se-
quences. To perform their effector function, siRNAs are incorpo-
rated into ribonucleoprotein complexes, which are referred to as
siRNA-induced silencing complexes (RISCs; acting post-transcrip-
tionally) or RNA-induced transcriptional silencing (RITS, acting at
the chromatin level) [3–5]. Dicer is responsible for the excision
of siRNAs from double-stranded (ds)RNA [6,7]. The function of Di-
cer is not conﬁned to siRNA biogenesis. Although the biological
importance and biochemistry of mammalian Dicer have been stud-
ied extensively, little is known about its protein partners. The onlychemical Societies. Published by E
nvironmental Sciences, Chiba
, Chiba 275-0016, Japan. Fax:
akaku).are members of the Argonaute family, which are siRNA-associated
core components of RISCs [3]. Human T-cell leukemia virus type I
(HTLV-I) gene expression is regulated by two virally encoded nu-
clear proteins that are termed Tax and Rex [8]. Tax is a DNA se-
quence-speciﬁc transcriptional trans-activator that markedly
enhances the expression of genes linked to the 50 long terminal re-
peat promoter element of the HTLV-I genome [9,10]. In addition,
by interacting with a number of cellular proteins, Tax inﬂuences
the survival, cell-cycle progression and growth of HTLV-I-infected
T-cells, and it induces genomic instability [10–12]. In contrast,
Rex acts post-transcriptionally to induce the cytoplasmic expres-
sion of incompletely spliced HTLV-I transcripts that encode the vir-
al structural gene products [13–16]. The cis-acting RNA target for
Rex coincides with a highly structured 254-nt RNA sequence
termed the Rex-response element (RxRE), which has been mapped
to the U3/R region of the HTLV-I long terminal repeat (Fig. 1B) [17].
Rex binds a structured 12-nt RNA sequence of the RxRE with high
afﬁnity and speciﬁcity in vitro [18]. Recently, several mammalian
viruses have been shown to encode RNA silencing suppressor
(RSS) proteins. These RSS proteins include inﬂuenza A virus NS1lsevier B.V. All rights reserved.
Fig. 1. Schematic representation of the constructs used in the present study. (A) HTLV-I-EGFP-region, Dicer target sites and the sequences used to design the HTC-EGFP-
shRNAs and Dicer-siRNA. (B) pHTC-EGFP-luc contains a cytomegalovirus promoter joined to EGFP and the ﬁreﬂy luciferase gene. pSRa-Rex-WT, pSRa-RexHA-WT, pcDNA-
RexHA-WT, and pQE30-Rex-WT contain the SRa, CMC, and PT5 promoters joined to Rex or RexHA, respectively. WT: wild-type. (C) Functional domains of HTLV-I Rex and the
speciﬁc amino acid substitution for each Rex mutant plasmid are shown. The functional domains of the 189-aa Rex-1 protein are depicted in shaded boxes. The nuclear
localization signal (NLS) and the RNA binding domain (RBD) are positioned within the ﬁrst 19 amino acids of the protein. The activation domain and the nuclear export signal
(NES) are located between residues 79 and 99. This region is ﬂanked by the two multimerization domains; the ﬁrst lies between amino acids 57 and 66, and the second spans
amino acids 106 to 124. A C-terminal stability domain was identiﬁed that spanned amino acids 170–189.
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M. Abe et al. / FEBS Letters 584 (2010) 4313–4318 4315(NS1) [19–21], vaccinia virus E3L (E3L) [20], primate foamy virus
type 1 (PFV-1) [22], HIV-1 Tat [23,24], hepatitis C virus Core and
envelope protein 2 [25,26], and an Ebola virus protein [21,27].
HIV-1 Tat and HCV core are thought to block Dicer activity
[23,28], whereas NS1, E3L and VP35 may act by sequestering dsR-
NAs and siRNAs [19,20].
In the present study, we investigated the effect of the interac-
tion between HTLV-I Rex and Dicer on shRNA. The interaction of
Dicer with HTLV-I Rex inhibited Dicer activity and thereby pre-
vented the production of siRNA from shRNA.2. Materials and methods
2.1. Cell culture
The 293T cells were propagated in Dulbecco’s Modiﬁed Eagle’s
Medium (low glucose, Sigma Chemical Co., St. Louis, MO) supple-
mented with 10% fetal bovine serum, non-essential amino acids,
and L-glutamine.
2.2. Plasmids and RNA synthesis
pHTC-GFP-luc, pSRa-Rex-WT, and pSRa-RexHA-WT have been
described previously [29,30]. The plasmid pcDNA-RexHA-WT was
constructed by inserting the PCR-ampliﬁed Rex-HA-WT cDNA
(primers: forward, 50-AACTGCAGGTGGACTCTAGAGGATCCC-30 and
reverse, 50-CCGGAATTCTCAAGCGTAGTCTGGGACGTCGTATGGGT-
ACGTGGGGCAGGAGGGGCCAG-30) [31], which contains a hemag-
glutinin (HA) tag, into the XbaI-EcoRI site of the pcDNA3.1 vector
(Invitrogen, Carlsbad, CA). The pQE30-Rex-WT plasmid was con-
structed by inserting the PCR-ampliﬁed Rex cDNA (primers: for-
ward, 50-GAC TGG ATC CAT GCC CAA GAC CCG TCG GAG-30 and
reverse, 50-AGT CGT CGA CTC ACG TGG GGC AGG AGG GGC-30) into
the BamHI and SalI sites of pQE30 (Qiagen GmbH, Hilden, Ger-
many). The pSRa-Rex mutant and pQE30-Rex mutant plasmids
were generated according to previously published procedures
(Fig. 1C and Supplementary Methods) [32–36]. The small RNAs
(siRNA and shRNA) were obtained from Hokkaido System Co. (Hok-
kaido, Japan).
2.3. Fluorescence microscopy
Fluorescence microscopy was used to investigate the efﬁciency
of enhanced green ﬂuorescent protein (EGFP) expression as an in-
dex of the cotransfection of 293T cells with 0.5 lg pHTC-EGFP-luc
and 25 nM siRNA (EGFP-shRNA, Dicer-siRNA, ran-EGFP-shRNA, and
EGFP-siRNA) or 0.5 lg pSRa-Rex-WT and pSRa-Rex mutants. The
293T cells were ﬁxed with 3.7% formaldehyde at day 2 post-
cotransfection. Fluorescent cells were examined using ﬂuorescence
microscopy (Biozero BZ-8000; KEYENCE, Osaka, Japan) at an exci-
tation wavelength of 488 nm using a 20 objective lens. Images
were acquired at a resolution of 512  512 pixels. The detector
gain and offset values were set to the appropriate levels for each
labeling experiment; non-cotransfected cells served as a negative
background control. For the ﬂuorimetry, we used an assay buffer
(100 mM HEPES, 0.5% Triton X-100, 1 mM CaCl2, and 1 mM b-
mercaptoethanol) and quantiﬁed the results using a Quad4 mono-
chromator-based 384-well plate reader by measuring the emission
at 508 nm after a 1-s excitation at 488 nm (Tecan, Salzburg,
Austria).
2.4. Ribonuclease protection assay
Total RNA was extracted from pHTC-GFP-luc transfected cells
using the RNeasy Plus Mini Kit (Qiagen GmbH, Hilden, Germany)according to the manufacturer’s instructions. A ribonuclease pro-
tection assay was performed using a RPA III Ribonuclease Protec-
tion Assay Kit (Ambion, Foster City, CA) as described previously
with some modiﬁcations. Total RNA (20 lg) was denatured
for 3 min in hybridization buffer (Ambion) at 95 C and hybridized
at 45 C overnight with 1 ll 50-DIG-labeled LNA/DNA probe
(100 lM hybridization buffer). Synthetic LNA/DNA oligonucleo-
tides (50-DIG-GGTAGGCTCCAAGGGAGCGCCGGACAAAG-30; Ther-
moElectron GmbH, Ulm, Germany) that were complementary to
the antisense strand (188–216) of the HTLV-I RxRE region were
used as probes. The hybrids were digested with RNase A (0.08 U)
and RNase T1 (3 U) at 37 C for 30 min and then analyzed in a
15% polyacrylamide gel containing 7 M urea. Following their trans-
fer to Hybond-NTM nylon membrane (GE Healthcare Bio-Sciences
Corp., Piscataway, NJ), four post-hybridization washes were per-
formed for 20 min each at 37 C with 2  SSC (1  SSC: 0.15 M
NaCl and 0.015 M sodium citrate-0.1% sodium dodecyl sulfate).
The LNA/DNA/RNA hybrids were detected using the CSPD chemilu-
minescent detection system (Roche Diagnostics GmbH, Germany).3. Results and discussion
3.1. HTLV-I Rex protein is a general suppressor of RNA silencing
HTLV-I RxRE activates interferon-induced 20,50-oligoadenylate
synthetase. In addition, RxRE activates a second interferon-induced
enzyme, PKR; however, RxRE also inhibits PKR activity. Poly(rl)-
poly(rC) dissociates the ribonucleoprotein complexes Rex-RE/2–
5-OAS and RxRE/PKR, whereas poly(rC) does not, which indicates
that high-afﬁnity interactions occur between RxRE and these two
enzymes [32]. Rex might inhibit the antiviral interferon-PKR-med-
iated cellular defense triggered by long dsRNA in part through an
RNA binding-dependent mechanism. In the present study, we
examined whether the interaction between Rex and Dicer in
293T cells inﬂuenced the shRNA efﬁcacy. As a proof of concept,
we used EGFP-targeted shRNA (EGFP-shRNA) as an index of
cotransfection (Fig. 1A). For this purpose, we used pHTC-EGFP-
luc (Fig. 1B) with a Rex response element (RxRE) within the tar-
get-RNA sequence (Rex). First, the 293T cells were transfected with
pHTC-EGFP-luc (0.5 lg) and a Dicer-speciﬁc siRNA (Dicer-siRNA;
0–25 nM; Fig. 1A). Dicer protein expression decreased in a dose-
dependent manner (Fig. 2A and Supplementary Methods), whereas
the expression level of HTLV-I p19 Gag protein increased in a dose-
dependent manner (Fig. 2B and Supplementary Methods). These
ﬁndings indicate that Dicer inﬂuences HTLV-I RNA expression.
Therefore, to investigate the effects of Dicer on the shRNA-medi-
ated silencing of HTLV-I RNA expression in target cells, we tested
shRNA targeted to EGFP in pHTC-EGFP-luc. Transfection of 293T
cells with EGFP-shRNA or EGFP-siRNA signiﬁcantly reduced EGFP
expression by 85% or 88% (Fig. 2C-d,e) in comparison to a control
transfection with pHTC-EGFP-luc alone (Fig. 2C-a). Furthermore,
EGFP expression was not reduced when pHTC-EGFP-luc-random
shRNA or pSRa-Rex-WT was transfected into 293T cells and
pHTC-EGFP-luc was used as a control for speciﬁcity (Fig. 2C-b,c).
Cotransfection of Dicer-siRNA, pHTC-EGFP-luc, and EGFP-shRNA
restored the level of EGFP expression (Fig. 2C-f). However, when
the EGFP-shRNA used in the above cotransfection experiment
was replaced with EGFP-siRNA, EGFP expression was not restored
(Fig. 2C-g). Furthermore, cotransfection of pHTC-EGFP-luc and
EGFP-shRNA into 293T cells overexpressing pSRa-Rex-WT restored
the level of EGFP expression (Fig. 2C-h). However, cotransfection of
pHTC-EGFP-luc and EGFP-siRNA into 293T cells overexpressing
pSRa-Rex-WT did not restore EGFP expression (Fig. 2C-j). To deter-
mine whether individual functional domains of Rex were required
for its ability to inhibit shRNA-mediated RNAi, we examined func-
Fig. 2. HTLV-I Rex protein–mediated post-transcriptional silencing. (A) The 293T cells cotransfected with Dicer-siRNA and pHTC-EGFP-luc were incubated for 48 h. Dicer
protein expression was analyzed by western blotting. (B) The 293T cells cotransfected with Dicer-siRNA and pHTC-EGFP-luc were incubated for 48 h. The production of p19
Gag was detected using an HTLV-I p19 Gag enzyme-linked immunosorbent assay. All experiments were performed in triplicate. (C) The 293T cells were transfected with
pHTC-EGFP-luc (a) or cotransfected with control, ran-EGFP-shRNA (b), pSRa-Rex-WT (c), EGFP-shRNA (d), EGFP-siRNA (e), EGFP-shRNA-Dicer-siRNA (f), EGFP-siRNA-Dicer-
siRNA (g), EGFP-shRNA-pSRa-Rex-WT (h), EGFP-siRNA-pSRa-Rex-WT (i), and the EGFP-shRNA-pSRa-Rex mutants (RRR5,6,7DDD (j), YW64,65DL (k), LL90,92AA (l), and
TFH119,120,121DL (m)), which were expressed from the pHTC-EGFP-luc vectors and monitored at 48 h post-transfection under a ﬂuorescence microscope with magniﬁcation
(10). EGFP, EGFP signal; DIC, differential interference contrast microscopy. The results represent the percentage of the control EGFP ﬂuorescence.
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LL90,92AA, and TFH119,120,121DL) (Fig. 1C) [32–36]. These Rex
mutants did not restore EGFP expression (Fig. 2Cj-m). Based on this
result, which was mediated via the wild-type Rex protein–Dicer
complex. Dicer activity was functionally blocked in the cells, which
indicated that the overexpressed wild-type Rex protein interacted
with Dicer and inhibited cleavage of EGFP mRNA by shRNA. This
result suggests that Dicer did not cleave the shRNA to produce
the siRNA.
3.2. HTLV-I Rex protein interacts with Dicer
In the presence of shRNA against EGFP, HTLV-I Rex overexpres-
sion restored the gene expression of EGFP. These results led us to
consider whether HTLV-I Rex affects the efﬁcacy of the shRNA-
mediated post-transcriptional gene silencing pathway in mamma-
lian cells. To examine this possibility, we evaluated the ability of
the recombinant Rex-WT protein and each of the Rex mutants
(RRR5,6,7DDD, YW64,65DL, LL90,92AA, and TFH119,120,121DL)(Fig. 1C) [32–36] to bind to Dicer. The 293T cell lysates were incu-
bated with His-tagged Rex-WT bound to Ni-NTA agarose and then
analyzed by immunoblotting to determine the amount of bound
Dicer. His-tagged Rex-WT was able to bind endogenous Dicer
(Fig. 3A and Supplementary Methods). This interaction was con-
ﬁrmed using an anti-Dicer antibody, which indicated that endoge-
nous Dicer coprecipitated with His-tagged Rex-WT (Fig. 3B and
Supplementary Methods). Recombinant Rex carrying either the
YW64,65DL or the TFH119,120,121DL mutations, which affect
the multimerization domain, displayed a severely reduced ability
to bind Dicer (Fig. 3C and Supplementary Methods). In contrast,
the NLS and RBD (RRR5,6,7DDD) and the NES (LL90,92AA) mutants
retained some Dicer binding activity (Fig. 3C and Supplementary
Methods). These data suggest that the multimerization of Rex-
WT plays a critical role in the interaction with Dicer.
Next, the localization of Rex protein in 293T cells was deter-
mined using western blotting and immunoﬂuorescence methods.
Rex protein was observed in both the cytoplasm and the nucleus
by western blotting (Supplementary Fig. s1A and Supplementary
Fig. 3. Interaction between HTLV-I Rex and Dicer. The 293T cell lysates were
incubated with His-tagged Rex-WT or Rex mutants (RRR5,6,7DDD, YW64,65DL,
LL90,92AA, and TFH119,120,121DL) and then puriﬁed using nickel-agarose (A) or a
Dynabeads-antibody complex (B). The level of Dicer and Rex-WT binding were
determined by western blot analysis using an anti-Dicer or anti-His antibody. (C)
The 293T cell lysates were incubated with 3 ll of anti-His antibody, 30 ll of protein
G-Dynabeads and recombinant Rex-WT or the indicated mutants. The beads were
washed with PBS containing 0.02% Tween 20. The immunocomplexes were eluted
by boiling with 20 ll of 5 sample buffer and analyzed by SDS–PAGE and western
blot analysis using an anti-Dicer antibody.
Fig. 4. Nuclease protection analysis of HITV-1 mRNA levels with or without pSRa-
Rex-WT. The 50-DIG labeled LNA/DNA oligonucleotides (50-DIG-GGTAGGCTC-
CAAGGGAGCGCCGGACAAAG-30) that were complementary to the antisense strand
(188-216) of the HTLV-I RxRE region were used as probes. (A) The 293T cells were
transfected with pHTC-EGFP-luc alone. (B) The 293T cells were cotransfected with
pHTC-EGFP-luc and pSRa-Rex-WT.
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experiment to detect Dicer and RexHA-WT in 293T cells (Supple-
mentary Fig. s1B and Supplementary Methods). Dicer colocalized
with Rex protein in both the cytoplasm and the nucleus. These re-
sults suggest that the HTLV-I Rex-Dicer interaction suppresses the
silencing function of these shRNAs.
3.3. Inhibition of RNAi function by Rex protein contributes to HTLV-I
RNA stability
The expression of the structural proteins of HTLV-I depends on
the interaction of the viral Rex transactivator with its highly struc-
tured cis-acting RNA target sequence RxRE. The cis-acting RNA tar-
get for Rex coincides with the RxRE, and it has been mapped to the
U3/R region of the HTLV-I long terminal repeat (Fig. 1B) [17]. The
Rex protein binds RxRE with high afﬁnity and speciﬁcity in vitro
[19]. In the present study, we used an RNase protection assay to
evaluate the stability of HTLV-I RNA containing Rex sequences in
the absence or presence of pSRa-Rex-WT in 293T cells. Synthetic
LNA/DNA oligonucleotides that were complementary to the anti-
sense strand (188–216) of the HTLV-I RxRE region were used as
probes. In 293T cells containing pHTC-EGFP-luc in the absence of
pSRa-Rex-WT, the HTLV-I RxRE mRNA completely disappeared
within 24 h (Fig. 4A). In contrast, in the presence of pSRa-Rex-
WT, HTLV-I RxRE mRNA was expressed in 293T cells after 48 h
(Fig. 4B), which suggested that Rex-WT protein had an important
role in stabilizing HTLV-I RNA. Therefore, overexpression of Rex-
WT protein acts directly on Dicer to protect against the cleavage
of HTLV-I Rex mRNA. These results support the ﬁnding that Rex-
WT protein directly suppresses the ribonuclease-directed process-
ing activity of Dicer.In conclusion, we demonstrated that HTLV-I Rex inhibits
shRNA-mediated RNAi in vitro either directly or indirectly by pre-
venting siRNA production. Rex protein directly suppresses the
ribonuclease-directed processing activity of Dicer. Studies de-
signed to clarify the details of the Rex–Dicer interaction are cur-
rently underway. Rex blocks RNAi silencing by subverting the
ability of Dicer to process the precursor dsRNA into siRNA.
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